Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, Outset Medical, Inc. reported revenue of $119M, up 5.1% year over year. Operating margin was -55.8% and net margin -68.3%, on a free-cash-flow margin of -39.4% with capital expenditure at 0.7% of revenue. Every figure is computed directly from OM's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $119M | -55.8% | -68.3% |
| FY2024 | $114M | -99.7% | -112.6% |
| FY2023 | $130M | -130.2% | -132.5% |
| FY2022 | $115M | -139.6% | -141.2% |
| FY2021 | $103M | -127.2% | -128.6% |
How does OM compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.